The Nanosonics (ASX:NAN) share price rocketed 25% higher in August

It was a great month for Nanosonics and its shareholders…

| More on:
Group of doctors celebrate by pumping fists in the air

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Nanosonics Ltd (ASX: NAN) share price was a very strong performer in August.

During the month, the infection prevention company's shares rose a sizeable 25%.

Why did the Nanosonics share price rocket higher in August?

The catalyst for the strong gain by the Nanosonics share price last month was the release of its full year results.

Not only did these results come in ahead of expectations, but the company also pleased the market by announcing a major new product.

Let's start with its results. For the 12 months ended 30 June, Nanosonics reported a 3% increase in revenue to $103.1 million and a 15% decline in net profit after tax to $8.6 million.

While a profit decline might not seem like something to celebrate, it was notably better than the market was expecting. This was driven by a stronger than expected second half recovery.

What about the new product?

As positive as the result was, the announcement of its new product may have given the Nanosonics share price the biggest lift.

That product is Nanosonics Coris, a flexible endoscopes disinfection system.

Management notes that more healthcare-associated outbreaks have been linked to contaminated endoscopes than any other medical device.

And with over 60 million flexible endoscopy procedures being conducted across the United States and the five largest markets in Europe each year, this provides it with a significant market opportunity in the coming years.

However, this product won't be boosting its FY 2022 results. This is because management is targeting a launch in calendar year 2023.

It is also worth noting that the company has a track record of failing to deliver on product launch promises. So, it isn't inconceivable that this launch date will get pushed back.

Is it too late to invest?

One leading broker that unfortunately believes it is too late to invest is Goldman Sachs.

Its analysts have recently retained their sell rating and cut their price target to $4.40.

Based on the latest Nanosonics share price of $6.67, this implies potential downside of 34% over the next 12 month.

Goldman commented: "We post FY22/23E sales upgrades of +6/+8% to factor the FY21 beat and FX gains, but incorporating new cost/margin guidance drives (19)/(25)% downgrades to our FY22/FY23E EBITDA forecasts, and a (11)% reduction in our TP to $4.40. Although this stock has not historically traded on near-term multiples, posting these downgrades drives 2022E trading multiples up to 125x EBITDA (180x P/E) valuations which would ordinarily be associated with much higher growth profiles (we now forecast sales/earnings CAGRs of +8%/+15 from FY22-25E)."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Nanosonics Limited. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX All Ords shares up 50%+ in March

These ASX shares have been on fire this month. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

These shares are having a good session on hump day. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Consumer Staples & Discretionary Shares

If you'd put $20,000 in this ASX retail stock at the start of 2023, you'd have $134,000 now

This online retailer has executed a remarkable turnaround for its investors.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX shares this Tuesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »